semaglutide alcohol use disorder study Wegovy and Ozempic (semaglutide) are associated with a 50-56% reduction in addiction Semaglutide and Tirzepatide reduce alcohol

Nov 05, 2025, 08:15 ET Post hoc analyses include data showing investigational oral semaglutide 25 mg use was associated with improvements in blood sugar control and cardiovascular (CV) risk factors across multiple categories of weight loss 1 Another analysis detailed an indirect trial comparison between oral semaglutide 25 mg and the currently available injectable form, showing comparable efficacy 2 In two additional analyses, oral semaglutide 25 mg was associated with the same weight loss efficacy in women with obesity regardless of menopausal stage, and patients reported improvements in physical function, respectively 3,4 PLAINSBORO, N.J

Cuenca-Zaldivar, A

Premature discontinuation before reaching therapeutic doses or adequate treatment duration prevents full pharmacological effect

Another promising direction involves mucoadhesive nanocarriers that anchor to intestinal epithelium and release GLP-1 analogs in a site-specific manner, minimizing systemic degradation [35]